VaxInnate Corporation Licenses Recombinant H1N1 Pandemic Swine Flu Vaccine to Biological E. Limited; Vaccine Could Become Available for Use in India This Year
CRANBURY, N.J.--(BUSINESS WIRE)--VaxInnate Corporation today announced that it has granted Indian biopharmaceutical company Biological E. Limited a license to its recombinant H1N1 pandemic swine flu vaccine and is collaborating to facilitate the manufacture, clinical development and commercialization of the vaccine in India.